Product Launchsurgical roboticsmedical imagingai mappingmedtronic
Medtronic Expands Stealth AXiS To Cranial, ENT
8.2
Medtronic said on March 28, 2026 the U.S. FDA cleared its Stealth AXiS surgical system for cranial and ear, nose and throat procedures, expanding the platform beyond a February spine indication. The system combines navigation, imaging, robotics and uses AI to auto-generate brain maps; the company also cut its fiscal 2026 profit forecast to $5.50–$5.54 after a roughly $157 million one-time charge.
Key Points
- 1Announces FDA clearance for Stealth AXiS in cranial and ENT surgeries with AI brain mapping
- 2Highlights integration of navigation, imaging, robotics to guide surgeons and reduce intraoperative imaging
- 3Signals broader platform expansion after spine clearance, impacting surgical workflow and device adoption
Scoring Rationale
Regulatory milestone with direct clinical applicability; limited novelty since it extends existing platform rather than introducing new capabilities.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
